Simplification of Complex Physiologically Based Pharmacokinetic Models of Monoclonal Antibodies

被引:0
|
作者
Mohamed Elmeliegy
Philip Lowe
Wojciech Krzyzanski
机构
[1] University at Buffalo—State University of New York,Department of Pharmaceutical Sciences, School of Pharmacy & Pharmaceutical Sciences
[2] Novartis Pharma AG,undefined
来源
The AAPS Journal | 2014年 / 16卷
关键词
compartmental models; monoclonal antibodies; PBPK;
D O I
暂无
中图分类号
学科分类号
摘要
Monoclonal antibodies (mAbs) exhibit biexponential profiles in plasma that are commonly described with a standard two-compartment model with elimination from the central compartment. These models adequately describe mAb plasma PK. However, these models ignore elimination from the peripheral compartment. This may lead to underestimation of the volume of distribution of the peripheral compartment and thus over-predicts concentration in the peripheral compartment. We developed a simple and physiologically relevant model that incorporates information on binding and dissociation rates between mAb and FcRn receptor, mAb uptake, reflection, and catabolic degradation. We employed a previously published PBPK model and, with assumptions regarding rates of processes controlling mAb disposition, reduced the complex PBPK model to a simpler circular model with central, peripheral, and lymph compartments specifying elimination from both central and peripheral. We successfully applied the model to describe the PK of an investigational mAb. Our model presents an improvement over standard two-compartmental models in predicting whole-body average tissue concentrations while adequately describing plasma PK with minimal complexity and physiologically more meaningful parameters.
引用
收藏
页码:810 / 842
页数:32
相关论文
共 50 条
  • [41] Have physiologically-based pharmacokinetic models delivered?
    Edginton, Andrea N.
    Joshi, Ghanashyam
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2011, 7 (08) : 929 - 934
  • [42] Applications of minimal physiologically-based pharmacokinetic models
    Yanguang Cao
    William J. Jusko
    Journal of Pharmacokinetics and Pharmacodynamics, 2012, 39 : 711 - 723
  • [43] Physiologically based pharmacokinetic models for everolimus and sorafenib in mice
    Dipti K. Pawaskar
    Robert M. Straubinger
    Gerald J. Fetterly
    Bonnie H. Hylander
    Elizabeth A. Repasky
    Wen W. Ma
    William J. Jusko
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1219 - 1229
  • [44] Examination of Physiologically-Based Pharmacokinetic Models of Rosuvastatin
    Bowman, Christine M.
    Ma, Fang
    Mao, Jialin
    Chen, Yuan
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (01): : 5 - 17
  • [45] Physiological parameter values for physiologically based pharmacokinetic models
    Brown, RP
    Delp, MD
    Lindstedt, SL
    Rhomberg, LR
    Beliles, RP
    TOXICOLOGY AND INDUSTRIAL HEALTH, 1997, 13 (04) : 407 - 484
  • [46] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELS IN DEVELOPMENTAL TOXICOLOGY
    FLAHERTY, EJ
    RISK ANALYSIS, 1994, 14 (04) : 605 - 611
  • [47] Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling
    Kumar, Mokshada
    Lanke, Sravani
    Yadav, Alka
    Ette, Mfonabasi
    Mager, Donald E.
    Shah, Dhaval K.
    ANTIBODIES, 2024, 13 (03)
  • [48] Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites
    Fisher, JW
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 : 265 - 273
  • [49] Physiologically based pharmacokinetic models for the transport of trichloroethylene in adipose tissue
    Albanese, RA
    Banks, HT
    Evans, MV
    Potter, LK
    BULLETIN OF MATHEMATICAL BIOLOGY, 2002, 64 (01) : 97 - 131
  • [50] Physiologically based pharmacokinetic models for the transport of trichloroethylene in adipose tissue
    R. A. Albanese
    H. T. Banks
    M. V. Evans
    L. K. Potter
    Bulletin of Mathematical Biology, 2002, 64 : 97 - 131